These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38164562)

  • 21. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
    Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
    Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-reported outcome measures for monitoring primary care patients with depression: the PROMDEP cluster RCT and economic evaluation.
    Kendrick T; Dowrick C; Lewis G; Moore M; Leydon GM; Geraghty AW; Griffiths G; Zhu S; Yao GL; May C; Gabbay M; Dewar-Haggart R; Williams S; Bui L; Thompson N; Bridewell L; Trapasso E; Patel T; McCarthy M; Khan N; Page H; Corcoran E; Hahn JS; Bird M; Logan MX; Ching BCF; Tiwari R; Hunt A; Stuart B
    Health Technol Assess; 2024 Mar; 28(17):1-95. PubMed ID: 38551155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body weight management in overweight and obese breast cancer survivors.
    Shaikh H; Bradhurst P; Ma LX; Tan SYC; Egger SJ; Vardy JL
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012110. PubMed ID: 33305350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A web-based, peer-supported self-management intervention to reduce distress in relatives of people with psychosis or bipolar disorder: the REACT RCT.
    Lobban F; Akers N; Appelbe D; Iraci Capuccinello R; Chapman L; Collinge L; Dodd S; Flowers S; Hollingsworth B; Honary M; Johnson S; Jones SH; Mateus C; Mezes B; Murray E; Panagaki K; Rainford N; Robinson H; Rosala-Hallas A; Sellwood W; Walker A; Williamson PR
    Health Technol Assess; 2020 Jun; 24(32):1-142. PubMed ID: 32608353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT.
    Bruce J; Mazuquin B; Mistry P; Rees S; Canaway A; Hossain A; Williamson E; Padfield EJ; Lall R; Richmond H; Chowdhury L; Lait C; Petrou S; Booth K; Lamb SE; Vidya R; Thompson AM
    Health Technol Assess; 2022 Feb; 26(15):1-124. PubMed ID: 35220995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examining relationships between age at diagnosis and health-related quality of life outcomes in prostate cancer survivors.
    Kurian CJ; Leader AE; Thong MSY; Keith SW; Zeigler-Johnson CM
    BMC Public Health; 2018 Aug; 18(1):1060. PubMed ID: 30139347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive exercise compared with best-practice advice, with or without corticosteroid injection, for rotator cuff disorders: the GRASP factorial RCT.
    Hopewell S; Keene DJ; Heine P; Marian IR; Dritsaki M; Cureton L; Dutton SJ; Dakin H; Carr A; Hamilton W; Hansen Z; Jaggi A; Littlewood C; Barker K; Gray A; Lamb SE
    Health Technol Assess; 2021 Aug; 25(48):1-158. PubMed ID: 34382931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients.
    McLachlan SA; Devins GM; Goodwin PJ
    Eur J Cancer; 1998 Mar; 34(4):510-7. PubMed ID: 9713301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme - a randomised controlled trial and economic evaluation.
    McRobbie H; Hajek P; Peerbux S; Kahan BC; Eldridge S; Trépel D; Parrott S; Griffiths C; Snuggs S; Myers Smith K
    Health Technol Assess; 2016 Oct; 20(79):1-150. PubMed ID: 27802843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. REDUCE (Reviewing long-term antidepressant use by careful monitoring in everyday practice) internet and telephone support to people coming off long-term antidepressants: protocol for a randomised controlled trial.
    Kendrick T; Geraghty AWA; Bowers H; Stuart B; Leydon G; May C; Yao G; O'Brien W; Glowacka M; Holley S; Williams S; Zhu S; Dewar-Haggart R; Palmer B; Bell M; Collinson S; Fry I; Lewis G; Griffiths G; Gilbody S; Moncrieff J; Moore M; Macleod U; Little P; Dowrick C
    Trials; 2020 May; 21(1):419. PubMed ID: 32448374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN' (REGAIN): a structured summary of a study protocol for a randomised controlled trial.
    McGregor G; Sandhu H; Bruce J; Sheehan B; McWilliams D; Yeung J; Jones C; Lara B; Smith J; Ji C; Fairbrother E; Ennis S; Heine P; Alleyne S; Guck J; Padfield E; Potter R; Mason J; Lall R; Seers K; Underwood M
    Trials; 2021 Jan; 22(1):8. PubMed ID: 33407804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of Life and Psychological Wellbeing of Colorectal Cancer Survivors in the KSA.
    Abu-Helalah M; Mustafa H; Alshraideh H; Alsuhail AI; A Almousily O; Al-Abdallah R; Al Olayan A
    Asian Pac J Cancer Prev; 2022 Apr; 23(4):1301-1308. PubMed ID: 35485689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design.
    Di Meglio A; Martin E; Crane TE; Charles C; Barbier A; Raynard B; Mangin A; Tredan O; Bouleuc C; Cottu PH; Vanlemmens L; Segura-Djezzar C; Lesur A; Pistilli B; Joly F; Ginsbourger T; Coquet B; Pauporte I; Jacob G; Sirven A; Bonastre J; Ligibel JA; Michiels S; Vaz-Luis I
    Trials; 2022 Mar; 23(1):193. PubMed ID: 35246219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
    Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.
    Tombal B; Saad F; Penson D; Hussain M; Sternberg CN; Morlock R; Ramaswamy K; Ivanescu C; Attard G
    Lancet Oncol; 2019 Apr; 20(4):556-569. PubMed ID: 30770294
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.